Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.
Mayuresh Joshi of Angel Broking feels that Ipca Laboratories may touch Rs 740.
Pritesh Mehta of IIFL is of the view that one may avoid Aurobindo Pharma.
Mayuresh Joshi of Angel Broking advises selling Wockhardt on rallies.
Dhananjay Sinha of Emkay Global Financial Services is overweight on IT and pharmaceuticals space.
Nirmal Jain, chairman of IIFL recommends buying Infotech Enterprises, HCL Technologies, Ipca Laboratories, Torrent Pharma and Dr Reddys Laboratories.
Tata Steel may see some kind of lower pressure as a breakdown on daily charts as per technicals. So one can take short position in Tata Steel at current market price with a stop loss of Rs 331, expect a target of Rs 307 in the next one-two trading sessions, says Vikrant Jadeja of vibranttrades.com.
Sharmila Joshi of Peerless Securities recommends buying Ipca Laboratories with a target of Rs 734 and PVR with a target of Rs 513.
Sharmila Joshi of Peerless Securities advises buying Ipca Laboratories with a target price of Rs 734 and PVR with a target price of Rs 513.
Lancelot D Cunha, CEO of Sharyans Wealth Management recommends buying Ipca Laboratories with a target of Rs 721 and advises selling Housing Development and Infrastructure (HDIL) Futures with a target of Rs 33.35.
Lancelot D Cunha, CEO of Sharyans Wealth Management Private Limited advised buying Ipca Labs with a target price of Rs 721 and LIC Housing Finance with a target price of Rs 164.
Aditya Agarwal, Way2Wealth Securities suggests buying Union Bank of India with a target of Rs 118-120 and Ipca Laboratories with a target of Rs 680-720.
Manas Jaiswal of manasjaiswal.com recommends buying Dish TV India with a target of Rs 52 and NMDC with target of Rs 120.
According to Sahil Kapoor of Edelweiss, one can buy Ipca Laboratories at current levels with a target of Rs 700 or even higher.
Sahil Kapoor of Edelweiss recommends buying Ipca Laboratories with a target of Rs 700 and keep a stoploss below Rs 620.
Rakesh Tarway Of Motilal Oswal Securities is positive on Wipro and Ipca Laboratories.
Prakash Diwan of Altamount Capital Management recommends buying Sun Pharma Advanced Research Company with a target price of Rs 134.50 and stop loss at Rs 127.50.
Aashish Tater of Fortunewizard.com advises to short HDIL with a target price of Rs 35 and Jain Irrigation with a target price Rs 46.5.
Rajesh Agarwal of Eastern Financiers recommends buying Mahindra Ugine Steel Company, Rasoya Proteins, Welspun Corp and Ipca Laboratories.
Rajesh Agarwal of Eastern Financiers advises to buy Mahindra Ugine for a target price of Rs 95.50 and Rasoya Proteins for a target price of Rs 13.
Manav Chopra, senior technical research analyst at Nirmal Bang Securities recommends a strong buy on Ipca Laboratories with a stop loss of Rs 680.
One can buy Ipca Laboratories and wait for gains in the next few days, feels Sudarshan Sukhani of s2analytics.com.
Pankaj Jain of Sunteck Wealthmax advises to short Unitech, Jubilant Foodworks and go long on Jet Airways and Ipca Labs
Aashish Tater, head of research at fortunewizard.com recommended buying PTC India with a target price of Rs 56 and selling Sun TV Network with a target price of Rs 342.
Prashant Nair of Citi India told CNBC-TV18 that the pharma sector's valuations in current market downturn situation has held up well. He presents his views on buzzing stocks from the sector.